Video: New Drug Proves Effective For Renal Cell Cancer Patients

Share this content:

The new drug called nivolumab combined with ipilimumab revealed manageable safety, antitumor activity and favorable responses garnering potential long-term benefits across the board in patients with metastatic renal cell cancer.

You must be a registered member of Renal and Urology News to post a comment.